Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 235

Similar articles for PubMed (Select 19706707)

1.

Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells.

Doehle BP, Hladik F, McNevin JP, McElrath MJ, Gale M Jr.

J Virol. 2009 Oct;83(20):10395-405. doi: 10.1128/JVI.00849-09. Epub 2009 Aug 12.

2.

Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism.

Doehle BP, Chang K, Rustagi A, McNevin J, McElrath MJ, Gale M Jr.

J Virol. 2012 Aug;86(16):8367-74. doi: 10.1128/JVI.00423-12. Epub 2012 May 16.

3.

Peripheral B cells may serve as a reservoir for persistent hepatitis C virus infection.

Ito M, Masumi A, Mochida K, Kukihara H, Moriishi K, Matsuura Y, Yamaguchi K, Mizuochi T.

J Innate Immun. 2010;2(6):607-17. doi: 10.1159/000317690. Epub 2010 Aug 17.

PMID:
20714117
4.

Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells.

Doehle BP, Chang K, Fleming L, McNevin J, Hladik F, McElrath MJ, Gale M Jr.

J Virol. 2012 Aug;86(16):8499-506. doi: 10.1128/JVI.00424-12. Epub 2012 May 30.

5.

Sustained activation of interferon regulatory factor 3 during infection by paramyxoviruses requires MDA5.

Grandvaux N, Guan X, Yoboua F, Zucchini N, Fink K, Doyon P, Martin L, Servant MJ, Chartier S.

J Innate Immun. 2014;6(5):650-62. doi: 10.1159/000360764. Epub 2014 Apr 30.

PMID:
24800889
6.

Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense.

Johnson CL, Owen DM, Gale M Jr.

J Biol Chem. 2007 Apr 6;282(14):10792-803. Epub 2007 Feb 8.

7.

Limited suppression of the interferon-beta production by hepatitis C virus serine protease in cultured human hepatocytes.

Dansako H, Ikeda M, Kato N.

FEBS J. 2007 Aug;274(16):4161-76. Epub 2007 Jul 25.

PMID:
17651439
8.

Induction of IRF-3 and IRF-7 phosphorylation following activation of the RIG-I pathway.

Paz S, Sun Q, Nakhaei P, Romieu-Mourez R, Goubau D, Julkunen I, Lin R, Hiscott J.

Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(1):17-28.

PMID:
16914100
9.

TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA.

Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J.

PLoS One. 2009 May 25;4(5):e5674. doi: 10.1371/journal.pone.0005674.

10.

RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I.

Solis M, Nakhaei P, Jalalirad M, Lacoste J, Douville R, Arguello M, Zhao T, Laughrea M, Wainberg MA, Hiscott J.

J Virol. 2011 Feb;85(3):1224-36. doi: 10.1128/JVI.01635-10. Epub 2010 Nov 17.

11.

ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation.

Lu G, Reinert JT, Pitha-Rowe I, Okumura A, Kellum M, Knobeloch KP, Hassel B, Pitha PM.

Cell Mol Biol (Noisy-le-grand). 2006 May 15;52(1):29-41.

PMID:
16914094
12.

Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response.

Xu C, He X, Zheng Z, Zhang Z, Wei C, Guan K, Hou L, Zhang B, Zhu L, Cao Y, Zhang Y, Cao Y, Ma S, Wang P, Zhang P, Xu Q, Ling Y, Yang X, Zhong H.

J Virol. 2014 Oct;88(19):11356-68. doi: 10.1128/JVI.01400-14. Epub 2014 Jul 23.

13.

Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells.

Nicol MQ, Mathys JM, Pereira A, Ollington K, Ieong MH, Skolnik PR.

J Virol. 2008 Aug;82(16):7790-8. doi: 10.1128/JVI.00362-08. Epub 2008 Jun 4.

14.

Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages.

Zheng N, Fujiwara M, Ueno T, Oka S, Takiguchi M.

J Virol. 2009 Aug;83(15):7668-77. doi: 10.1128/JVI.00513-09. Epub 2009 May 20.

15.

Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling.

Sun L, Xing Y, Chen X, Zheng Y, Yang Y, Nichols DB, Clementz MA, Banach BS, Li K, Baker SC, Chen Z.

PLoS One. 2012;7(2):e30802. doi: 10.1371/journal.pone.0030802. Epub 2012 Feb 1.

16.

Induction of IFN-beta and the innate antiviral response in myeloid cells occurs through an IPS-1-dependent signal that does not require IRF-3 and IRF-7.

Daffis S, Suthar MS, Szretter KJ, Gale M Jr, Diamond MS.

PLoS Pathog. 2009 Oct;5(10):e1000607. doi: 10.1371/journal.ppat.1000607. Epub 2009 Oct 2.

17.

Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity.

Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, Akira S, Gill MA, García-Sastre A, Katze MG, Gale M Jr.

J Virol. 2008 Jan;82(1):335-45. Epub 2007 Oct 17.

18.

Human endothelial cells enhance human immunodeficiency virus type 1 replication in CD4+ T cells in a Nef-dependent manner in vitro and in vivo.

Choi J, Walker J, Boichuk S, Kirkiles-Smith N, Torpey N, Pober JS, Alexander L.

J Virol. 2005 Jan;79(1):264-76.

19.

Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.

tenOever BR, Sharma S, Zou W, Sun Q, Grandvaux N, Julkunen I, Hemmi H, Yamamoto M, Akira S, Yeh WC, Lin R, Hiscott J.

J Virol. 2004 Oct;78(19):10636-49.

20.

T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication.

Berg RK, Rahbek SH, Kofod-Olsen E, Holm CK, Melchjorsen J, Jensen DG, Hansen AL, Jørgensen LB, Ostergaard L, Tolstrup M, Larsen CS, Paludan SR, Jakobsen MR, Mogensen TH.

PLoS One. 2014 Jan 3;9(1):e84513. doi: 10.1371/journal.pone.0084513. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk